Browse by Attribute
Browse by Column

FDA Approves New Indication for Wyeth's TYGACIL

2009/03/27

Wyeth Pharmaceuticals, a division of Wyeth, announced that the US Food and Drug Administration (FDA) approved TYGACIL (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.

 

According to Wyeth, TYGACIL was first approved by the FDA in 2005 for the treatment of complicated intra-abdominal infections (cIAI) and complicated skin and skin structure infections (cSSSI) caused by susceptible strains of indicated pathogens in adults.

 

“The approval of this new indication is timely.  Antibiotic resistance continues to grow and new antimicrobials are needed,” Wyeth Pharmaceuticals Senior Vice President, Global Medical Affairs, Joseph Camardo said.

 

“The approval of TYGACIL for CABP is an important milestone in Wyeth’s commitment to exploring new treatment options in the anti-infective therapeutic area,” he added.

 

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women’s health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation.

 

SOURCE:AGIPNEWS




Click Ranking

People watch


Chen Jun: Accumulation and Sublimation
It is lucky for Chen Jun to began his career in the IP industry 14 years ago when the first group of IP managers for businesses appeared on the stage in China and he has been in the industry.

Foxconn in Those Years
It was this “Whampoa Military Academy” for IP that educated China’s first batch of corporate IP management personnel. Many of these engineers left Foxconn in the years since.

more
2018 ANNUAL INVENTORY OF THE The Progress and Challenges of Copyright Industry in China Interview with Cheng Lingjun, Intellectual Property Director of Joyoung Co., Ltd. Interview with Chen Lingpei, General Manager of IP Division, Autodesk, Inc. (Greater China) Constant Accumulation Makes theLatecomers Surpass—Interview with Huang Lu, Director of IP Center of Humanwell Healthcare Between Lawyer and Manager —Interview with Xia Feng, the Chief IP Counsel of Greater China & Asia-Pacific, Honeywell (China) Patent Prosecution Highway and its Application Overview of EU copyright levy system – in the case of mobile phones